BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

9144 related articles for article (PubMed ID: 1696446)

  • 21. Three distinct antigen systems on human B cell subpopulations as defined by monoclonal antibodies.
    Takami T; Ishii Y; Yuasa H; Kikuchi K
    J Immunol; 1985 Feb; 134(2):828-34. PubMed ID: 3917477
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fascin, a sensitive new marker for Reed-Sternberg cells of hodgkin's disease. Evidence for a dendritic or B cell derivation?
    Pinkus GS; Pinkus JL; Langhoff E; Matsumura F; Yamashiro S; Mosialos G; Said JW
    Am J Pathol; 1997 Feb; 150(2):543-62. PubMed ID: 9033270
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Immunoperoxidase study of normal and pathologic lymphoid tissue. Value of monoclonal antibodies].
    Delsol G; Al Saati T; Caveriviere P; Voigt JJ; Ancelin E; Rigal-Huguet F
    Ann Pathol; 1984; 4(3):165-83. PubMed ID: 6383412
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Utilization of monoclonal antibody L26 in the identification and confirmation of B-cell lymphomas. A sensitive and specific marker applicable to formalin-and B5-fixed, paraffin-embedded tissues.
    Cartun RW; Coles FB; Pastuszak WT
    Am J Pathol; 1987 Dec; 129(3):415-21. PubMed ID: 3322020
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunohistochemical analysis of the distribution of lymphocyte subpopulations in Hodgkin's disease.
    Borowitz MJ; Croker BP; Metzgar RS
    Cancer Treat Rep; 1982 Apr; 66(4):667-74. PubMed ID: 6210433
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SC3 monoclonal antibody defines a novel specific human B-cell surface antigen differentially expressed on B-cell leukaemias and lymphomas and involved in the proliferation of normal and malignant B lymphocytes.
    Nikolova M; Guenova M; Taskov H; Marie-Cardine A; Boumsell L; Bensussan A
    Cell Immunol; 2005; 236(1-2):92-100. PubMed ID: 16197933
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vascular endothelial growth factor (VEGF) is expressed by neoplastic Hodgkin-Reed-Sternberg cells in Hodgkin's disease.
    Doussis-Anagnostopoulou IA; Talks KL; Turley H; Debnam P; Tan DC; Mariatos G; Gorgoulis V; Kittas C; Gatter KC
    J Pathol; 2002 Aug; 197(5):677-83. PubMed ID: 12210089
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cellular distribution of a B-cell specific surface antigen (gp54) detected by a monoclonal antibody (anti-BL4).
    Hashimi L; Wang CY; Al-Katib A; Koziner B
    Cancer Res; 1986 Oct; 46(10):5431-7. PubMed ID: 3093065
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monoclonal antibody SN10 which shows a highly selective reactivity with human B leukemia-lymphoma and is effectively internalized into cells.
    Takeuchi T; Barcos MP; Seon BK
    Cancer Res; 1991 Jun; 51(11):2985-93. PubMed ID: 1709587
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hodgkin's disease: an immunohistochemical and histological study.
    Curran RC; Jones EL
    J Pathol; 1978 May; 125(1):39-51. PubMed ID: 569193
    [TBL] [Abstract][Full Text] [Related]  

  • 31. T and B lymphocytes and Reed-Sternberg cells in Hodgkin's disease lymph nodes and spleens.
    Payne SV; Jones DB; Haegert DG; Smith JL; Wright DH
    Clin Exp Immunol; 1976 May; 24(2):280-6. PubMed ID: 1084241
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuron-specific enolase (gamma enolase, gamma-gamma dimer) expression in Hodgkin's disease and large cell lymphomas.
    Massarelli G; Onida GA; Piras MA; Marras V; Mura A; Tanda F
    Anticancer Res; 1999; 19(5B):3933-8. PubMed ID: 10628334
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Histiocyte-rich B-cell lymphoma. A distinct clinicopathologic entity possibly related to lymphocyte predominant Hodgkin's disease, paragranuloma subtype.
    Delabie J; Vandenberghe E; Kennes C; Verhoef G; Foschini MP; Stul M; Cassiman JJ; De Wolf-Peeters C
    Am J Surg Pathol; 1992 Jan; 16(1):37-48. PubMed ID: 1728195
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD40 ligand is constitutively expressed in a subset of T cell lymphomas and on the microenvironmental reactive T cells of follicular lymphomas and Hodgkin's disease.
    Carbone A; Gloghini A; Gruss HJ; Pinto A
    Am J Pathol; 1995 Oct; 147(4):912-22. PubMed ID: 7573367
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preparation and characterization of monoclonal antibodies recognizing three distinct differentiation antigens (BL1, BL2, BL3) on human B lymphocytes.
    Wang CY; Azzo W; Al-Katib A; Chiorazzi N; Knowles DM
    J Immunol; 1984 Aug; 133(2):684-91. PubMed ID: 6429242
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The demonstration of B-cell, T-cell and myeloid antigens in paraffin sections.
    West KP; Warford A; Fray L; Allen M; Campbell AC; Lauder I
    J Pathol; 1986 Oct; 150(2):89-101. PubMed ID: 3540244
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dendritic reticulum cell immunoreactivity for low-affinity nerve growth factor receptor in malignant lymphomas.
    Dorfman DM; Shahsafaei A
    Mod Pathol; 1996 Oct; 9(10):959-65. PubMed ID: 8902831
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PB76: a novel surface glycoprotein preferentially expressed on mouse pre-B cells and plasma cells detected by the monoclonal antibody G-5-2.
    Strasser A
    Eur J Immunol; 1988 Nov; 18(11):1803-10. PubMed ID: 3060363
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A new antigen identified by the monoclonal antibody UCHB 1 delivers a costimulatory signal to a subset of human B cells.
    Armitage RJ; Rowe DJ; Beverly PC
    Eur J Immunol; 1988 Jan; 18(1):67-76. PubMed ID: 3257923
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cultural, morphological, cell membrane, enzymatic, and neoplastic properties of cell lines derived from a Hodgkin's disease lymph node.
    Roberts AN; Smith KL; Dowell BL; Hubbard AK
    Cancer Res; 1978 Sep; 38(9):3033-43. PubMed ID: 209894
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 458.